CRCM
Crystal Rock Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.96M | Sell |
64,770
-4,550
| -7% | -$489K | 4.01% | 9 |
|
|
2025
Q1 | $6.99M | Sell |
69,320
-15,780
| -19% | -$1.59M | 4.78% | 7 |
|
|
2024
Q4 | $7.6M | Sell |
85,100
-6,425
| -7% | -$574K | 4.66% | 8 |
|
|
2024
Q3 | $7.67M | Sell |
91,525
-3,350
| -4% | -$281K | 4.52% | 8 |
|
|
2024
Q2 | $7.31M | Hold |
94,875
| – | – | 4.37% | 8 |
|
|
2024
Q1 | $6.5M | Hold |
94,875
| – | – | 3.78% | 9 |
|
|
2023
Q4 | $5.48M | Sell |
94,875
-4,500
| -5% | -$260K | 3.62% | 10 |
|
|
2023
Q3 | $5.25M | Hold |
99,375
| – | – | 4% | 8 |
|
|
2023
Q2 | $5.38M | Hold |
99,375
| – | – | 3.98% | 9 |
|
|
2023
Q1 | $4.97M | Sell |
99,375
-18,000
| -15% | -$901K | 4.12% | 11 |
|
|
2022
Q4 | $5.43M | Hold |
117,375
| – | – | 4.68% | 7 |
|
|
2022
Q3 | $4.55M | Buy |
117,375
+8,800
| +8% | +$341K | 4.68% | 7 |
|
|
2022
Q2 | $4.05M | Buy |
108,575
+6,000
| +6% | +$224K | 3.84% | 13 |
|
|
2022
Q1 | $4.54M | Hold |
102,575
| – | – | 3.01% | 16 |
|
|
2021
Q4 | $4.36M | Hold |
102,575
| – | – | 2.35% | 18 |
|
|
2021
Q3 | $4.45M | Buy |
102,575
+3,600
| +4% | +$156K | 2.37% | 19 |
|
|
2021
Q2 | $4.23M | Hold |
98,975
| – | – | 2.2% | 19 |
|
|
2021
Q1 | $3.83M | Sell |
98,975
-8,200
| -8% | -$317K | 2.08% | 20 |
|
|
2020
Q4 | $3.85M | Sell |
107,175
-8,300
| -7% | -$298K | 2.2% | 20 |
|
|
2020
Q3 | $4.41M | Hold |
115,475
| – | – | 2.78% | 11 |
|
|
2020
Q2 | $4.05M | Buy |
115,475
+8,400
| +8% | +$295K | 2.8% | 14 |
|
|
2020
Q1 | $3.49M | Buy |
107,075
+77,075
| +257% | +$2.52M | 3.08% | 15 |
|
|
2019
Q4 | $1.36M | Buy |
+30,000
| New | +$1.36M | 0.89% | 29 |
|